After ethics committee approval, 51 consenting ASA physical status 1 or 2 adult patients were given basal flow sevoflurane anaesthesia using fresh gas flows of 150 to 300 ml.min -1 oxygen. A Komesaroff vaporizer was placed on the inspiratory limb of the circle system. Basal flows were introduced immediately following intravenous induction of anaesthesia. The vaporizer was set to deliver the maximum concentration until the inspired sevoflurane concentration (FSI) reached 3%. The dial was then adjusted to maintain the FSI at 3%. After every 60 minutes, the circuit was washed out with 100% oxygen at a flow rate of 10 l.min -1 for one minute.
Sevoflurane has many desirable properties that make it a very useful anaesthetic agent. It has a low blood:gas solubility coefficient which allows rapid anaesthetic induction and emergence. Its non-irritant nature is useful in patients with reactive airways such as smokers and asthmatics. However, despite the advantages its use has been limited as it is currently the most expensive volatile anaesthetic agent in the United Kingdom.
The use of basal flow anaesthesia optimizes the benefits of rebreathing, such as cost savings, humidification, heat conservation, and reduced pollution. However, at basal flows in the region of 250 ml.min -1 , a vaporizer outside the circle system (VOC) will not be able to deliver sufficient vapour during the rapid uptake of the induction phase 1, 2 . Therefore, it is necessary to use high fresh gas flows during anaesthetic induction with the inevitable wastage of sevoflurane during the initial stages of anaesthesia. As the fresh gas flows are subsequently reduced, less sevoflurane is vaporized and wastage is diminished.
It is, however, possible to employ basal flows from the onset of anaesthesia, provided the rate of delivery of the volatile agent to the patient is sufficient. This can only be achieved either by the use of a vaporizer inside the circle (VIC) or by the injection of liquid anaesthetic into the circuit 2 .
Plenum vaporizers are unsuitable for use as VIC because their high resistance impedes spontaneous breathing and their high efficiency may cause a dangerous build-up of anaesthetic concentration. On the other hand, the Komesaroff vaporizer offers low resistance and less efficiency, and is therefore suitable as a VIC. It is a variable-bypass, non-agent specific vaporizer with five settings, i.e. 'off', 'on' and three intermediate settings. At both the 'on' and 'off' settings it offers minimal resistance. It has a glass bowl that is calibrated to 30 ml in 2 ml steps diagonally around the bowl 1, 3 .
In this study, basal flow oxygen was used in combination with sevoflurane administered via a Komesaroff vaporizer as VIC. The aim of the study was to eliminate the wastage of sevoflurane and to demonstrate the maximum possible savings, when using a totally closed system with basal flows of oxygen throughout the procedure.
Materials and Methods: Following local Research
Ethics Committee approval, written informed consent was obtained from all patients. Fifty-one consecutive adult patients (ASA 1 or 2) undergoing general anaesthesia for elective surgery were studied. Both mechanically ventilated (IPPV) and spontaneously ventilated (SV) patients were included. The authors administered all the anaesthetics. The Datex-Ohmeda Aestiva 3000 (Datex Ohmeda, Helsinki, Finland) anaesthetic machine with built-in bag-in-bottle ventilator was used. The inspired (FSI) and expired (FSE) concentrations of sevoflurane, oxygen and carbon dioxide were monitored continuously with the Datex Ohmeda AS/3 gas analyser. The gas analyser was calibrated monthly according to the manufacturer's instructions using calibration gas. The sampled gas was returned to the expiratory limb of the circle system. Prior to each procedure, the circle system including the soda lime canister and the ventilator circuit were checked for leaks according to the manufacturer's instructions. A heat and moisture exchanger was placed on the patient end of the circle system. A Komesaroff vaporizer filled with 10 ml sevoflurane was attached to the inspiratory limb of the circle system. The vaporizer was topped up when empty, each time with 10 ml of sevoflurane.
None of the patients received premedication. Intravenous midazolam 0.04 mg.kg -1 and fentanyl 1.0 µg.kg -1 were administered in the anaesthetic room. The patients were then transferred to the operating theatre and preoxygenated for three minutes with 6 l.min -1 of 100% oxygen. General anaesthesia was induced with intravenous propofol 2.5 mg.kg -1 . A laryngeal mask airway (LMA) was then inserted for the SV patients and ventilation assisted manually to maintain end-tidal CO 2 at 35 to 40 mmHg until normal spontaneous ventilation was resumed. Thereafter, increments of morphine 0.03 mg.kg -1 were given at 15-minute intervals to maintain the ventilatory rate at 10-20 breaths.min -1 . For the IPPV patients, rocuronium 0.6 mg.kg -1 was given and the trachea intubated after 60 to 70 seconds. Tidal volume of 6 ml.kg -1 and ventilatory rate of 10 breaths.min -1 were set initially and subsequently adjusted as necessary to maintain an end-tidal CO 2 level of 35 to 40 mmHg. Increments of morphine 0.03 mg.kg -1 were given at 15-minute intervals.
After intravenous induction, the oxygen flow was immediately reduced to 250 ml.min -1 and the Komesaroff vaporizer set to deliver the maximum concentration of sevoflurane (dial position 4). The adjustable pressure-limiting (APL) valve was completely closed in both groups of patients. The oxygen flow was then adjusted according to the patient's requirements to prevent the ventilator bellows from collapsing, the flow ranging between 150 and 300 ml.min -1 . Once the FSI reached 3% and was maintained at that level for two minutes, the Komesaroff dial setting was reduced as necessary to maintain a FSI of 3% throughout the procedure. After each 60 minutes, the circuit was flushed with 100% oxygen at 10 l.min -1 for one minute with the vaporizer turned off and the APL valve fully open. Basal flow anaesthesia was then resumed. At the conclusion of the procedure the vaporizer was turned off and the oxygen flow increased to 6 l.min -1 . The muscle relaxant, if used, was reversed at this time and the LMA or the endotracheal tube removed.
The FSI and FSE were recorded at one-minute intervals for the first 30 minutes, and every five minutes thereafter until the end of the anaesthetic. The heart rate and the blood pressure were recorded every three minutes for the first 30 minutes and every five minutes thereafter. The respiratory rate, tidal volume, F E CO 2 , F I O 2 , and SpO 2 were recorded every three minutes for the first 30 minutes and every 15 minutes thereafter. The total volume of liquid sevoflurane used was measured at the end of the anaesthetic. The time taken for the patient to open eyes to verbal command, after turning the vaporizer off, was also recorded.
Statistical Methods: The primary outcome measure was the hourly liquid sevoflurane consumption (ml). Mann-Whitney U test and the Chi-square test were used to compare the data between the SV and IPPV groups. In the case of the time-related variables described above, a linear regression slope was constructed for each patient to obtain an estimate of the time trend for each variable. These linear regression slopes were then compared for each variable, between the IPPV and SV groups using the Mann-Whitney U test. Table 1 shows the patient characteristics and Table  2 , the surgical procedures performed. The anaesthetic related time data are shown in Table 3 . There were no significant differences between the IPPV and the SV groups.
RESULTS
Overall, the mean (SD) liquid sevoflurane consumption per hour was 9.2 (2.8) ml. This was 8.9 (3.2) ml in the IPPV group and 9.4 (2.5) ml in the SV group (P=0.25). The rate of sevoflurane consumption ranged from 5.3 to 17.1 ml per hour in inverse proportion to the duration of anaesthesia (Figure 1) . Figures 2 and 3 show the FSI and FSE during the first 60 minutes of anaesthesia. The differences in trends in both FSI (P=0.028) and FSE (P=0.049) between the IPPV and SV groups were statistically significant.
The mean vaporizer dial settings during the initial 60 minutes of anaesthesia are shown in Figure 4 . There was a significant difference between the trends in the IPPV and the SV groups (P=0.031).
There was a gradual reduction in the F I O2 over time. However none of the patients had F I O2 lower than 40% at any time or required adjustment in oxygen flow to increase their F I O2. The hourly flushing of the circuit with oxygen invariably restored the F I O2 to a higher level.
No clinically significant cardiovascular or respiratory depression was observed in any of the patients. The trends in the parameters were statistically similar between the IPPV and the SV groups (P>0.05).
DISCUSSION
In his editorial 4 , Baker commented on minimal gas inflow anaesthetic techniques as follows: "It is very economic in these times of cost consciousness and costly new volatile anaesthetic agents, and as well, allows a close observation and understanding of the patient's pathophysiology by monitoring oxygen consumption ... Trainee anaesthetists should not consider themselves au fait with general anaesthesia until they are able to give a successful minimal gas flow anaesthetic with understanding of the principles involved." Modern technology has revolutionized the way both the patient and the anaesthetic are monitored. As a consequence, basal flow anaesthesia and VIC anaesthesia have become safe provided meticulous monitoring is applied. Dhara and Liu in their study of VIC sevoflurane anaesthesia using the Komesaroff vaporizer found that it was simple and safe during both controlled and spontaneous ventilation, provided that sevoflurane concentrations were continuously monitored 3 .
The present study has demonstrated that it is S. P. NaNdalaN, R. J. EltRiNgham, Q. W. FaN possible to achieve both induction and maintenance of sevoflurane anaesthesia using basal flow from the outset with a VIC technique after an intravenous induction. In this way both the initial high gas flows and consequent wastage of sevoflurane were avoided. With this technique a FSI of 3% was achieved at 8.5 (3.8) minutes. There was a significant difference in the way the sevoflurane concentrations built up in the IPPV and the SV groups. A more gradual build-up was noticed in the IPPV group. This would be anticipated considering the individual variations between patients and their respiratory response to the various depths of anaesthesia when spontaneously breathing. Upon recovery, the mean time from the discontinuation of the anaesthetic to the time to respond to verbal command was 10.5 (6.6) minutes. Frink and colleagues found that the recovery of eye-opening to command was 7.5 (0.5) minutes with sevoflurane as opposed to 18.6 (2.0) minutes for isoflurane when anaesthesia was maintained at one MAC each 5 . We attribute the delayed recovery of consciousness of our patients to our targeting of higher sevoflurane concentrations. After achieving the FSI of 3%, the mean FSE was 2.5 (0.1) % in our patients, which is near to 1.3 MAC, the MAC being 2.05. We assume 1.3 MAC as sufficient to suppress movement to skin incision in 95% of patients 6, 7 . In the methodology we used a FSI of 3% as our target to simplify the study.
This target has proven to be satisfactory by achieving FSE near to 1.3 MAC.
The commonest dial settings for the Komesaroff vaporizer were found to be 4 for the first 11 minutes, 2 for the next 13 minutes and 1.5 thereafter until 60 minutes. Although this may serve as a guide to those who wish to use this technique in their practice, meticulous monitoring of agent concentrations must nevertheless be ensured. No difficulty in maintaining adequate sevoflurane concentrations was encountered. Dhara and Liu pointed out that the sevoflurane concentrations were steady when the volume of liquid sevoflurane in the vaporizer was between 15 to 30 ml 3 . When the residual volume was less than 15 ml higher vaporizer settings were needed. In the present study the volume of sevoflurane in the vaporizer was restricted to 10 ml in order to reduce non-clinical wastage after each anaesthetic.
Nitrous oxide was not used as part of the anaesthetic technique. There is a view that when nitrous oxide is used at fresh gas flows lower than 500 ml.min -1 , the limits of safe performance of conventional anaesthetic machines are reached. The omission of nitrous oxide on the other hand facilitates the routine use of even lower fresh gas flows 8 .
Toxicity Issues: The degradation of sevoflurane when in contact with soda lime and the subsequent formation of Compound A (CpA) had been a source CoSt-EFFECtivENESS oF BaSal FloW SEvoFluRaNE of major concern in the past. Although CpA has been shown to be nephrotoxic in rats, no evidence for nephrotoxicity or hepatotoxicity has been shown in humans 9 . Numerous studies have proved the safety of low flow and closed circuit sevoflurane anaesthesia of both short and long duration [10] [11] [12] [13] . These studies which addressed both CpA formation and free fluoride formation with the use of sevoflurane, found no evidence of toxicity in humans. No relationship was found between the plasma fluoride concentrations and the total fresh gas flow rates 10 . Therefore, we believe that basal flow anaesthesia does not pose any danger in relation to plasma fluoride levels. Studies which compared low-flow isoflurane anaesthesia with low-flow sevoflurane anaesthesia in relation to their effects on hepatic and renal function, found that both agents were equally safe and did not cause any hepatic or renal dysfunction even in patients with pre-existing stable renal insufficiency [12] [13] .
In this study, the circuit was flushed every hour to ensure washout of any degradation products including nitrogen, methane, hydrogen and carbon monoxide 14 . Amsorb, a KOH-and NaOH-free CO 2 absorbent, has been shown not to produce CpA when used with sevoflurane [15] [16] [17] . Using such a compound, we believe, will remove the concerns in relation to the breakdown products of sevoflurane.
Economy: The cost for sevoflurane in the U.K. is £123.00 for a 250 ml bottle 18 . This is much higher in comparison to desflurane (£48.85 for 240 ml) and isoflurane (£27.00 for 250 ml). In basal flow VIC anaesthesia, the minimum possible amount of sevoflurane is vaporized with no wastage whatsoever. We noted that the longer the duration of anaesthesia, the less was the rate of consumption of sevoflurane. This can be attributed to the initial rapid uptake of sevoflurane and subsequent slowing of uptake once the tissues become saturated.
Mapleson calculated the ideal fresh-gas flow sequence required for low-flow anaesthesia with VOC 19 . Ip-Yam and co-workers applied this model in clinical practice 20 . They used oxygen flow 5 l.min -1 for one minute reducing to 1 l.min -1 thereafter. To maintain one MAC sevoflurane FSE, they used vaporizer settings of 3 MAC for the first minute, 2.5 MAC for the next 6 minutes and 1.8 MAC thereafter. Considering the density (1.52 g.ml -1 ) and molecular weight (200) of sevoflurane and using calculations based on the gas laws, the hourly sevoflurane consumption to provide a MAC of 2.05 using this sequence would be 15.8 ml at 20°C. However, the mean FSE after equilibration in our study was 2.5 (0.1)% and to achieve this value, the hourly sevoflurane consumption would have been 19.4 ml at 20°C.
Using the basal flow VIC technique, the hourly consumption of sevoflurane was only 9.2 (2.8) ml. One hour of anaesthesia with this technique in the U.K. would cost just £4.53 whereas a low-flow technique would cost £9.54 using the ideal fresh gasflow sequence and VOC. This is a 52.5% cost saving over the latter. Low-flow enthusiasts would routinely use the Mapleson's ideal fresh gas flow sequence. However, much higher fresh gas flows are likely to be encountered in routine low-flow anaesthesia. Therefore the actual benefits of adopting the basal flow VIC technique would be higher than anticipated.
We conclude that basal flow sevoflurane anaesthesia with the Komesaroff vaporizer placed within the circle is a suitable technique for maintenance of anaesthesia following an intravenous induction. This technique reduces the consumption of sevoflurane to the absolute minimum, providing an opportunity for significant savings and conservation of resources. Meticulous monitoring of airway gases is mandatory to ensure patient safety.
